Covered recipient · General Payments record
LARRY SKELTON
General Payments · PY2018–2023
$3,857.46
- Reported across 275 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $489.11 | 26 |
| Education | $94.00 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $161.94 | 12 |
| Lilly USA, LLC | $134.81 | 4 |
| Astellas Pharma US Inc | $94.00 | 1 |
| Novo Nordisk AS | $45.82 | 3 |
| Azurity Pharmaceuticals, Inc. | $36.52 | 1 |
| Ultragenyx Pharmaceutical Inc. | $22.33 | 1 |
| PFIZER INC. | $22.13 | 1 |
| DEXCOM, INC. | $20.57 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.94 | 1 |
| Exact Sciences Corporation | $16.59 | 1 |
| Corium, Inc. | $11.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $12.52 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999040237 | CMS |
| AbbVie Inc. | $21.02 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999040239 | CMS |
| AbbVie Inc. | $1.62 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999040241 | CMS |
| AbbVie Inc. | $16.46 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999040243 | CMS |
| AbbVie Inc. | $9.90 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999040245 | CMS |
| AbbVie Inc. | $7.70 | 04/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999040247 | CMS |
| AbbVie Inc. | $19.90 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999040249 | CMS |
| AbbVie Inc. | $29.21 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999040251 | CMS |
| AbbVie Inc. | $7.60 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999040253 | CMS |
| AbbVie Inc. | $3.31 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999040255 | CMS |
| AbbVie Inc. | $17.96 | 08/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999040257 | CMS |
| AbbVie Inc. | $14.74 | 09/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999040259 | CMS |
| Astellas Pharma US Inc | $94.00 | 03/10/2023 | Education | Undisputed | 01/23/2026 | 1033963381 | CMS |
| Azurity Pharmaceuticals, Inc. | $36.52 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 989000863 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.94 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996687713 | CMS |
| Corium, LLC | $11.46 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978135655 | CMS |
| Dexcom, Inc. | $20.57 | 11/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060218951 | CMS |
| Exact Sciences Corporation | $16.59 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1027395021 | CMS |
| Lilly USA, LLC | $17.38 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031903285 | CMS |
| Lilly USA, LLC | $80.52 | 06/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031828477 | CMS |
| Lilly USA, LLC | $18.69 | 08/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031903289 | CMS |
| Lilly USA, LLC | $18.22 | 08/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031762551 | CMS |
| Novo Nordisk Inc | $15.65 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005908219 | CMS |
| Novo Nordisk Inc | $14.27 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005908213 | CMS |
| Novo Nordisk Inc | $15.90 | 07/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005908227 | CMS |
| PFIZER INC. | $22.13 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049556381 | CMS |
| Ultragenyx Pharmaceutical Inc. | $22.33 | 03/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059055741 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.